Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells

Carcinogenesis

Volumn 34, Issue 8, 2013, Pages 1843-1851

  Chao, Che Yi ^a   Lii, Chong Kuei ^a,b   Hsu, Ya Ting ^b   Lu, Chia Yang ^c   Liu, Kai Li ^c,d   Li, Chien Chun ^c,d   Chen, Haw Wen ^b  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGRAPHOLIDE; BILIRUBIN; CARBON MONOXIDE; GELATINASE B; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL STRAIN MCF 7; DNA BINDING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84881493942     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt131     Document Type: Article

References (53)

1. American Cancer Society. (2007) Cancer Facts & Figures 2007. American Cancer Society, Atlanta, GA.
2. Lin, C.W. et al. (2008) Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol. Cancer Ther., 7, 1195-1206.
3. Gialeli, C. et al. (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J., 278, 16-27.
4. Overall, C.M. et al. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer, 2, 657-672.
5. Roy, R. et al. (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol., 27, 5287-5297.
6. Pellikainen, J.M. et al. (2004) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin. Cancer Res., 10, 7621-7628.
7. Ramírez, G. et al. (2011) Absence of Thy-1 results in TGF-ß induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts. Lab. Invest., 91, 1206-1218.
8. Youn, U.J. et al. (2011) 3-Deoxysappanchalcone inhibits tumor necrosis factor-a-induced matrix metalloproteinase-9 expression in human keratinocytes through activated protein-1 inhibition and nuclear factorkappa B DNA binding activity. Biol. Pharm. Bull., 34, 890-893.
9. Park, J.H. et al. (2010) Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol. Cells, 29, 209-215.
10. Jung, J.S. et al. (2012) Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways. Pharmacol. Res., 66, 95-103.
11. Ling, H. et al. (2011) Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res. Treat., 126, 609-620.
12. Weng, C.J. et al. (2008) Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis, 29, 147-156.
13. Negi, A.S. et al. (2008) Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. Med. Res. Rev., 28, 746-772.
14. Roxas, M. et al. (2007) Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern. Med. Rev., 12, 25-48.
15. Wang, L.J. et al. (2011) Andrographolide inhibits oral squamous cell carcinogenesis through NF-κB inactivation. J. Dent. Res., 90, 1246-1252.
16. Chen, H.W. et al. (2011) Inhibition of TNF-a-Induced Inflammation by andrographolide via down-regulation of the PI3K/Akt signaling pathway. J. Nat. Prod., 74, 2408-2413.
17. Trivedi, N.P. et al. (2009) Potency of andrographolide as an antitumor compound in BHC-induced liver damage. Integr. Cancer Ther., 8, 177-189.
18. Jiang, X. et al. (2009) Synthesis and evaluation of antibacterial activities of andrographolide analogues. Eur. J. Med. Chem., 44, 2936-2943.
19. Lee, Y.C. et al. (2010) Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via downregulation of PI3K/Akt signaling pathway. Eur. J. Pharmacol., 632, 23-32.
20. Shi, M.D. et al. (2008) Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem. Biol. Interact., 174, 201-210.
21. Pratheeshkumar, P. et al. (2012) Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression. Immunopharmacol. Immunotoxicol., 34, 143-151.
22. Otterbein, L.E. et al. (2000) Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung Cell. Mol. Physiol., 279, L1029-L1037.
23. Farombi, E.O. et al. (2006) Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J. Biochem. Mol. Biol., 39, 479-491.
24. Jozkowicz, A. et al. (2007) Heme oxygenase-1 in tumors: is it a false friend? Antioxid. Redox Signal., 9, 2099-2117.
25. Ferrando, M. et al. (2011) Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. Angiogenesis, 14, 467-479.
26. Hill, M. et al. (2005) Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J., 19, 1957-1968.
27. Rajagopal, S. et al. (2003) Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J. Exp. Ther. Oncol., 3, 147-158.
28. Yu, A.L. et al. (2010) Induction of heme oxygenase 1 and inhibition of tumor necrosis factor alpha-induced intercellular adhesion molecule expression by andrographolide in EA.hy926 cells. J. Agric. Food Chem., 58, 7641-7648.
29. Yang, Y.C. et al. (2013) Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways. J. Nutr. Biochem., 24, 204-212.
30. Giulietti, A. et al. (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods, 25, 386-401.
31. Cheng, W.L. et al. (2004) Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway. J. Agric. Food Chem., 52, 71-78.
32. Chu, S.C. et al. (2004) Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol. Carcinog., 40, 143-149.
33. Tang, S.C. et al. (2011) Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer. Cancer, 117, 3209-3221.
34. Nomura, N. et al. (2007) Phorbol 12-myristate 13-acetate (PMA)-induced migration of glioblastoma cells is mediated via p38MAPK/Hsp27 pathway. Biochem. Pharmacol., 74, 690-701.
35. Taylor, C.J. et al. (2006) Protein kinase C and downstream signaling pathways in a three-dimensional model of phorbol ester-induced angiogenesis. Angiogenesis, 9, 39-51.
36. Takahra, T. et al. (2004) Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int. J. Biochem. Cell Biol., 36, 353-363.
37. Casanova, F. et al. (2012) Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest. J. Cell. Biochem., 113, 2586-2596.
38. Duo, J. et al. (2012) Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation. Mol. Med. Rep., 5, 1453-1456.
39. Lim, J.C. et al. (2012) Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin. Exp. Pharmacol. Physiol., 39, 300-310.
40. Chun, J.Y. et al. (2010) Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer, 1, 868-876.
41. Chao, H.P. et al. (2010) Andrographolide exhibits anti-invasive activity against colon cancer cells via inhibition of MMP2 activity. Planta Med., 76, 1827-1833.
42. Pratheeshkumar, P. et al. (2011) Andrographolide inhibits human umbilical vein endothelial cell invasion and migration by regulating MMP-2 and MMP-9 during angiogenesis. J. Environ. Pathol. Toxicol. Oncol., 30, 33-41.
43. Johnson, M.D. et al. (1999) Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp. Cell Res., 247, 105-113.
44. Choi, J.H. et al. (2010) Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression. Food Chem. Toxicol., 48, 564-571.
45. Somiari, S.B. et al. (2006) Circulating MMP2 and MMP9 in breast cancer - potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int. J. Cancer, 119, 1403-1411.
46. Chen, H.H. et al. (2012) 4-Ketopinoresinol, a novel naturally occurring ARE activator, induces the Nrf2/HO-1 axis and protects against oxidative stress-induced cell injury via activation of PI3K/AKT signaling. Free Radic. Biol. Med., 52, 1054-1066.
47. Becker, J.C. et al. (2007) Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer. Scand. J. Gastroenterol., 42, 852-858.
48. Caballero, F. et al. (2004) Immunohistochemical analysis of heme oxygenase- 1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis. Int. J. Exp. Pathol., 85, 213-222.
49. Lu, D.Y. et al. (2012) Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. Neuro. Oncol., 14, 1367-1378.
50. Lin, P.H. et al. (2013) TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation. Oncogene, 32, 2325-2334.
51. Chung, H.T. et al. (2013) Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation. Methods Enzymol., 441, 329-338.
52. Parfenova, H. et al. (2012) Antioxidant roles of heme oxygenase, carbon monoxide, and bilirubin in cerebral circulation during seizures. J. Cereb. Blood Flow Metab., 32, 1024-1034.
53. Park, S.K. et al. (2009) Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdeltamediated signaling in MCF-7 human breast cancer cells. Carcinogenesis, 30, 1225-1233.